Lamivudine

EPZICOM (abacavir and lamivudine tablets)

EPZICOM (abacavir and lamivudine tablets)

EPZICOM tablets contain the following 2 synthetic nucleoside analogues: abacavir (ZIAGEN, also a component of TRIZIVIR) and lamivudine (also known as EPIVIR or 3TC) with inhibitory activity against HIV-1.

ABACAVIR, LAMIVUDINE and ZIDOVUDINE tablets

ABACAVIR, LAMIVUDINE and ZIDOVUDINE tablets

Abacavir, lamivudine and zidovudine tablet, a combination of abacavir, lamivudine, and zidovudine, each nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

TRIUMEQ (abacavir, dolutegravir, and lamivudine tablets)

TRIUMEQ (abacavir, dolutegravir, and lamivudine tablets)

TRIUMEQ contains an INSTI (dolutegravir) and 2 nucleoside analogues (abacavir and lamivudine) with inhibitory activity against HIV. TRIUMEQ is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and in pediatric patients weighing at least 40 kg.

Abacavir and Lamivudine Tablets USP

Abacavir and Lamivudine Tablets USP

Abacavir and lamivudine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.

Adblock Detected!

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by whitelisting our website.